Covaxin safe, shows 77.8% efficacy against symptomatic Covid: Lancet

Two doses of Covaxin, India's indigenous COVID-19 vaccine, offer 77.8 per cent protection against symptomatic disease and present no serious safety concerns, according to an interim analysis of its......

'Mumbai will always be vulnerable'

'If we have to restrict and fight terrorism, first and foremost, we have to ensure communal harmony in the country.' IMAGE: Pakistani terrorist Ajmal Kasab at the Chhatrapati Shivaji Terminus on......

Biological E inks deal with Canadian firm for mRNA Covid vaccine

Providence will sell up to 30 mn doses of its mRNA vaccine to Biological E. It would also provide the necessary technology transfer to make the vaccine in India, with a minimum production capacity......

Is this Indian Covid vaccine better than Pfizer's?

India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six......

Covid-19 could be the boost Indian pharma cos need

The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and......

Reliance hosts world's largest virtual AGM

As many as 3.2 lakh shareholders attended the meeting on the newly-minted JioMeet platform from 550 cities in 48 countries. Photograph: ANI Photo Reliance Industries Ltd, the country's most......

Ola, Uber see low demand after resuming services

Ola and Uber said they have resumed services in areas within orange and green zones, and have introduced requirements like wearing masks to ensure safety of riders and driver partners. IMAGE:......

SoftBank-backed Ola raises $500-mn term loan

Ola is likely to use the loan to fuel its vision for future of mobility across businesses including ride-hailing, vehicle commerce, delivery with foods, quick commerce & financial services.......